|
|
|
Search for: "Bayer"
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
HSMN NewsFeed,
31 Aug 2010:
Biopharmaceuticals
[J&JPRD, Johnson & Johnson, rivaroxaban, venous thromboembolism, DVT]
|
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer
HSMN NewsFeed,
18 Aug 2010:
Biopharmaceuticals, Oncology, FDA
[ImmunoGen, lorvotuzumab mertansine, lung cancer]
|
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
HSMN NewsFeed,
20 Jul 2010:
Biopharmaceuticals, Personnel
[Seaside Therapeutics]
|
Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
HSMN NewsFeed,
28 Jun 2010:
Biopharmaceuticals
[Bayer HealthCare Pharmaceuticals, FactorTrack, hemophilia, factor VIII]
|
Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
HSMN NewsFeed,
17 Jun 2010:
Biopharmaceuticals, Regenerative Medicine, Oncology
[Bayer HealthCare, Bayer Schering Pharma, OncoMed Pharmaceuticals, stem cell]
|
OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
HSMN NewsFeed,
17 Jun 2010:
Biopharmaceuticals, Regenerative Medicine, Oncology
[OncoMed Pharmaceuticals, Bayer Schering Pharma, stem cell, OMP-18R5]
|
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
HSMN NewsFeed,
14 Jun 2010:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, NSCLC]
|
Bayer Presents Clinical Data on Alpharadin in Metastatic Castration-Resistant Prostate Cancer (CRPC)
HSMN NewsFeed,
4 Jun 2010:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Alpharadin, radium-223 chloride, prostate cancer]
|
Seattle Genetics Names Vice President, Sales and Announces Management Promotion
HSMN NewsFeed,
24 May 2010:
Biopharmaceuticals, Personnel
[Seattle Genetics]
|
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
HSMN NewsFeed,
7 May 2010:
Biopharmaceuticals, FDA
[Bayer HealthCare Pharmaceuticals, Natazia, estradiol valerate, dienogest]
|
Cempra Pharmaceuticals Names Mark W. Hahn as Executive Vice President and Chief Financial Officer
HSMN NewsFeed,
6 May 2010:
Biopharmaceuticals, Personnel
[Cempra Pharmaceuticals]
|
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
HSMN NewsFeed,
3 May 2010:
Biopharmaceuticals, Personnel
[VIVUS]
|
Ardea Biosciences, Inc. Announces Appointment of Stephen R. Davis as Executive Vice President and Chief Operating Officer
HSMN NewsFeed,
12 Apr 2010:
Biopharmaceuticals, Personnel
[Ardea Biosciences]
|
Elekta Names New Head of Asia Pacific Organization
HSMN NewsFeed,
26 Mar 2010:
Devices, Oncology, Neurosurgery, Personnel
[Elekta]
|
FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis
HSMN NewsFeed,
11 Mar 2010:
Biopharmaceuticals, Drug Delivery, FDA
[Bayer HealthCare Pharmaceuticals, ciprofloxacin dry powder]
|
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
HSMN NewsFeed,
8 Mar 2010:
Biopharmaceuticals, Personnel
[Afraxis]
|
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
HSMN NewsFeed,
22 Feb 2010:
Biopharmaceuticals, Personnel
[Acorda Therapeutics]
|
Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
HSMN NewsFeed,
9 Feb 2010:
Biopharmaceuticals, Personnel
[Ardea Biosciences]
|
ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality
HSMN NewsFeed,
17 Dec 2009:
Biopharmaceuticals, Oncology, Personnel
[ImmunoGen]
|
Seattle Genetics and Millennium: The Takeda Oncology Company Announce Strategic Collaboration for Novel Late-Stage Lymphoma Program Brentuximab Vedotin (SGN-35)
HSMN NewsFeed,
15 Dec 2009:
Biopharmaceuticals, Oncology
[Seattle Genetics, Millennium, Takeda Pharmaceutical, brentuximab vedotin]
|
William D. Young to Become Chairman of Biogen Idec
HSMN NewsFeed,
10 Dec 2009:
Biopharmaceuticals, Personnel
[Biogen Idec]
|
Canaan Partners Appoints Tim Shannon, M.D. as Venture Partner
HSMN NewsFeed,
1 Dec 2009:
Venture Capital, Personnel
[Canaan Partners, CuraGen]
|
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
HSMN NewsFeed,
30 Nov 2009:
Biopharmaceuticals, Devices, Radiology, Neurology
[Bayer HealthCare, florbetaben, PET imaging, amyloid, Alzheimer's]
|
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
HSMN NewsFeed,
23 Oct 2009:
Biopharmaceuticals, Oncology
[Onyx Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Nexavar, sorafenib]
|
Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
HSMN NewsFeed,
19 Oct 2009:
Biopharmaceuticals, FDA
[Endo Pharmaceuticals, FORTESTA, testosterone, hypogonadism]
|
CalciMedica Appoints Evelyn Graham to its Board of Directors
HSMN NewsFeed,
13 Oct 2009:
Biopharmaceuticals, Personnel
[CalciMedica]
|
Seattle Genetics Names Head of Commercial and Announces Management Promotion
HSMN NewsFeed,
13 Oct 2009:
Biopharmaceuticals, Personnel
[Seattle Genetics]
|
Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
HSMN NewsFeed,
12 Oct 2009:
Biopharmaceuticals, Oncology, Mergers & Acquisitions
[Proteolix, Onyx Pharmaceuticals, carfilzomib]
|
Onyx Pharmaceuticals to Acquire Proteolix, Inc.
HSMN NewsFeed,
12 Oct 2009:
Biopharmaceuticals, Oncology, Mergers & Acquisitions
[Onyx Pharmaceuticals, Proteolix, carfilzomib]
|
Results Reported for Exploratory Phase 2 Study of Nexavar in Combination With Chemotherapeutic Agent Paclitaxel for Treatment of Advanced Breast Cancer
HSMN NewsFeed,
30 Sep 2009:
Biopharmaceuticals, Oncology
[Onyx Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Nexavar, sorafenib]
|
Micromet Appoints Former Roche Oncology Clinical Leader Jan Fagerberg as Chief Medical Officer
HSMN NewsFeed,
22 Sep 2009:
Biopharmaceuticals, Personnel
[Micromet , antibody]
|
Bayer's Novel Anti-Cancer Compound Regorafenib (BAY 73-4506) Showed Stabilization or Regression in 81 Percent of Kidney Cancer Patients
HSMN NewsFeed,
22 Sep 2009:
Biopharmaceuticals, Oncology
[Bayer HealthCare, egorafenib, BAY 73-4506, renal cell carcinoma]
|
GENova names Dr. John Savin as Vice President
HSMN NewsFeed,
4 Sep 2009:
Biopharmaceuticals, Oncology, Personnel
[GENova Biotherapeutics]
|
Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
HSMN NewsFeed,
25 Aug 2009:
Biopharmaceuticals, Personnel
[Adamas Pharmaceuticals]
|
Regeneron Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
HSMN NewsFeed,
24 Jul 2009:
Biopharmaceuticals, Regulatory
[Regeneron Pharmaceuticals, rilonacept, Cryopyrin-Associated Periodic Syndromes]
|
Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
HSMN NewsFeed,
22 Jul 2009:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, breast cancer]
|
Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer
HSMN NewsFeed,
2 Jun 2009:
Biopharmaceuticals, Personnel
[Bionovo]
|
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
HSMN NewsFeed,
1 Jun 2009:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, NSCLC, lung cancer]
|
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
HSMN NewsFeed,
20 May 2009:
Biopharmaceuticals, Oncology, Regulatory
[Bayer HealthCare Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Impax Receives FDA Approval for Generic Precose Tablets, 25 mg, 50 mg and 100 mg
HSMN NewsFeed,
19 May 2009:
Biopharmaceuticals, Generics, Endocrinology
[Impax Laboratories, Bayer HealthCare Pharmaceuticals, Precose, acarbose]
|
Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
HSMN NewsFeed,
11 May 2009:
Biopharmaceuticals, Oncology, Acquisitions
[sanofi-aventis, Antisoma, Oforta, fludarabine, B-cell CLL]
|
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
HSMN NewsFeed,
30 Apr 2009:
Biopharmaceuticals, Ophthalmology
[Regeneron Pharmaceuticals, Bayer HealthCare, VEGF Trap-Eye, CRVO]
|
New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes
HSMN NewsFeed,
29 Apr 2009:
Biopharmaceuticals, Neurology
[Bayer HealthCare Pharmaceuticals, Betaseron, interferon beta-1b]
|
Testosterone Undecanoate Achieves and Maintains Normal Testosterone Levels in Hypogonadal Men With Five Injections Per Year, New Data Show
HSMN NewsFeed,
28 Apr 2009:
Biopharmaceuticals
[Endo Pharmaceuticals, NEBIDO, testosterone undecanoate, hypogonadism]
|
Cerulean Pharma Inc. Announces Appointment of Oliver S. Fetzer as President and Chief Executive Officer
HSMN NewsFeed,
8 Apr 2009:
Biopharmaceuticals, Personnel
[Cerulean Pharma]
|
Aerovance Secures $38 Million in Equity Financing
HSMN NewsFeed,
7 Apr 2009:
Devices, Drug Delivery, Venture Capital
[Aerovance, Aerovant, asthma]
|
EPIX Pharmaceuticals Announces Sale of U.S., Canadian and Australian Rights for MS-325 (formerly marketed as Vasovist, gadofosveset trisodium, by Bayer Schering Pharma) to Lantheus Medical Imaging, Inc.
HSMN NewsFeed,
7 Apr 2009:
Biopharmaceuticals, Radiology, Acquisitions
[EPIX Pharmaceuticals, Lantheus Medical Imaging, Vasovist, gadofosveset]
|
Teva Announces Approval of Generic Yaz Tablets
HSMN NewsFeed,
1 Apr 2009:
Biopharmaceuticals, Generics, FDA
[Teva Pharmaceutical, Bayer Healthcare, Yaz, Drospirenone, Ethinyl Estradiol]
|
Seattle Genetics Receives FDA Fast Track Designation for SGN-35 for the Treatment of Hodgkin Lymphoma
HSMN NewsFeed,
30 Mar 2009:
Biopharmaceuticals, Oncology, FDA
[Seattle Genetics, SGN-35, Hodgkin lymphoma, Hodgkin's lymphoma]
|
American Medical Systems Announces New General Manager of BPH Therapy Business
HSMN NewsFeed,
24 Mar 2009:
Devices, Personnel
[American Medical Systems]
|
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
HSMN NewsFeed,
12 Mar 2009:
Biopharmaceuticals, FDA
[Endo Pharmaceuticals, NEBIDO, testosterone, hypogonadism]
|
Shire Announces Launch of FOSRENOL(R) in Japan
HSMN NewsFeed,
11 Mar 2009:
Biopharmaceuticals, Regulatory
[Shire Plc, Bayer Yakuhin, FOSRENOL, lanthanum carbonate]
|
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
HSMN NewsFeed,
23 Feb 2009:
Biopharmaceuticals, Personnel
[Micromet , blinatumomab]
|
Aerovance Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer
HSMN NewsFeed,
9 Feb 2009:
Biopharmaceuticals, Personnel
[Aerovance]
|
MEDRAD Sponsors PET Research with University of Zurich
HSMN NewsFeed,
6 Jan 2009:
Devices, Drug Delivery, Radiology, Oncology
[MEDRAD, fluorodeoxyglucose, FDG, PET Scan]
|
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed,
5 Jan 2009:
Biopharmaceuticals, Mergers & Acquisitions
[Indevus Pharmaceuticals, Endo Pharmaceuticals, NEBIDO]
|
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
HSMN NewsFeed,
31 Dec 2008:
Biopharmaceuticals, Drug Delivery, Acquisitions
[Nektar Therapeutics, Novartis, Tobramycin]
|
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
HSMN NewsFeed,
22 Dec 2008:
Biopharmaceuticals, Radiology
[EPIX Pharmaceuticals, Vasovist, gadofosveset trisodium, MRA agent]
|
Antisoma receives FDA approval for oral fludarabine, plans commercialisation deal to bring drug to US patients
HSMN NewsFeed,
19 Dec 2008:
Biopharmaceuticals, Oncology, FDA
[Antisoma, fludarabine, chronic lymphocytic leukaemia]
|
FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
HSMN NewsFeed,
1 Dec 2008:
Biopharmaceuticals, Oncology
[Cell Therapeutics, Spectrum Pharmaceuticals, Zevalin]
|
TorreyPines Therapeutics Appoints Evelyn Graham Chief Executive Officer and a Member of the Board of Directors
HSMN NewsFeed,
12 Nov 2008:
Biopharmaceuticals, Personnel
[TorreyPines Therapeutics]
|
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
HSMN NewsFeed,
21 Oct 2008:
Biopharmaceuticals, Acquisitions
[Nektar Therapeutics, Novartis AG]
|
FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
HSMN NewsFeed,
10 Oct 2008:
Biopharmaceuticals, FDA
[Bayer HealthCare, Kogenate FS, Antihemophilic Factor, hemophilia, factor VIII]
|
Seattle Genetics Adds to Senior Management Team
HSMN NewsFeed,
30 Sep 2008:
Biopharmaceuticals, Personnel
[Seattle Genetics]
|
Medimetriks Pharmaceuticals, Inc. Welcomes Wolfgang Kunze to Its Board of Directors
HSMN NewsFeed,
22 Sep 2008:
Biopharmaceuticals, Dermatology, Personnel
[Medimetriks Pharmaceuticals]
|
Betaseron(R) to Offer the Thinnest Needle in Multiple Sclerosis
HSMN NewsFeed,
15 Sep 2008:
Biopharmaceuticals, Drug Delivery, Neurology
[Bayer HealthCare, Betaseron, interferon beta-1b, multiple sclerosis]
|
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
HSMN NewsFeed,
12 Sep 2008:
Diagnostics, Personnel
[Power3 Medical Products]
|
Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
HSMN NewsFeed,
10 Sep 2008:
Biopharmaceuticals, Personnel
[Ferring Pharmaceuticals]
|
EPIX Pharmaceuticals To Regain Full Worldwide Commercial Rights For Vasovist(R)
HSMN NewsFeed,
4 Sep 2008:
Biopharmaceuticals, Radiology
[EPIX Pharmaceuticals, Bayer Schering Pharma, Vasovist, gadofosveset trisodium]
|
Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
HSMN NewsFeed,
3 Sep 2008:
Biopharmaceuticals, Personnel
[Wyeth]
|
Confirma and MEDRAD Partner to Advance Patient Care in the European Union
HSMN NewsFeed,
27 Aug 2008:
Devices, Radiology
[Confirma , MEDRAD, CADstream]
|
Avantis Medical Systems, Inc. Announces Key Leadership Appointments
HSMN NewsFeed,
25 Aug 2008:
Devices, Personnel
[Avantis Medical Systems]
|
Regeneron and Bayer HealthCare Announce VEGF Trap-Eye Achieved Durable Improvement in Vision over 52 Weeks in a Phase 2 Study in Patients with Age-Related Macular Degeneration
HSMN NewsFeed,
19 Aug 2008:
Biopharmaceuticals, Opthalmology
[Regeneron Pharmaceuticals, Bayer HealthCare AG, macular degeneration, VEGF Trap]
|
Onyx Pharmaceuticals Names Juergen Lasowski, Ph.D. as Senior Vice President of Corporate Development
HSMN NewsFeed,
15 Aug 2008:
Biopharmaceuticals, Personnel
[Onyx Pharmaceuticals]
|
MEDRAD Receives FDA 510(k) Clearance for Wireless MR Infusion System
HSMN NewsFeed,
11 Aug 2008:
Devices, FDA
[MEDRAD, Continuum Wireless, MR Infusion System]
|
Craig W. Philips Takes Helm at CTI
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals, Personnel
[Cell Therapeutics]
|
Oscient Pharmaceuticals Promotes Mark A. Glickman to Senior Vice President, Sales and Marketing
HSMN NewsFeed,
30 Jul 2008:
Biopharmaceuticals, Personnel
[Oscient Pharmaceuticals]
|
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Submits New Drug Application to FDA for Rivaroxaban
HSMN NewsFeed,
30 Jul 2008:
Biopharmaceuticals, FDA
[Johnson & Johnson, J&JPRD, rivaroxaban, deep vein thrombosis, pulmonary embolism]
|
EPIX Pharmaceuticals Announces Resignation of CEO; Names Elkan Gamzu Interim CEO
HSMN NewsFeed,
28 Jul 2008:
Biopharmaceuticals, Personnel
[EPIX Pharmaceuticals]
|
Nexavar Approved for Liver Cancer in China
HSMN NewsFeed,
28 Jul 2008:
Biopharmaceuticals, Oncology, Regulatory
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Predictive Biosciences Expands Executive Leadership Team with Two Diagnostic Industry Veteran Appointments
HSMN NewsFeed,
16 Jul 2008:
Diagnostics, Personnel
[Predictive Biosciences]
|
EPIX Pharmaceuticals Announces South Korean Approval of Vasovist(R); Novel Contrast Agent Now Approved for Marketing in 34 Countries
HSMN NewsFeed,
10 Jul 2008:
Biopharmaceuticals, Radiology, Regulatory
[EPIX Pharmaceuticals, Vasovist, gadofosveset trisodium]
|
Agile Therapeutics Appoints Senior Executive Jeffrey Frick as Chief Business Officer
HSMN NewsFeed,
8 Jul 2008:
Biopharmaceuticals, Personnel
[Agile Therapeutics]
|
FDA Approves EOVIST(R) to Detect and Characterize Focal Liver Lesions
HSMN NewsFeed,
8 Jul 2008:
Biopharmaceuticals, Radiology, FDA
[Bayer HealthCare, EOVIST, Gadoxetate Disodium, contrast agent]
|
Bayer HealthCare and Maxygen Announce Hematology Agreement
HSMN NewsFeed,
2 Jul 2008:
Biopharmaceuticals, Licensing, Acquisitions
[Maxygen, Bayer HealthCare, Factor VIIa, MAXY-VII, hemophilia]
|
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals
[EPIX Pharmaceuticals, Vasovist, gadofosveset, magnetic resonance angiography]
|
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, FDA
[Indevus Pharmaceuticals, NEBIDO, testosterone]
|
Wyeth Pharmaceuticals Announces Organizational Change
HSMN NewsFeed,
26 Jun 2008:
Biopharmaceuticals, Personnel
[Wyeth]
|
Barr and Bayer Sign Supply and Licensing Agreements for Launch of Generic Yasmin(R) and Yaz(R) Oral Contraceptives
HSMN NewsFeed,
24 Jun 2008:
Biopharmaceuticals, Generics, Licensing
[Barr Pharmaceuticals, Bayer, Yasmin, Yaz, drospirenone, ethinyl estradiol]
|
ArQule Announces Appointment of Brian Schwartz as Chief Medical Officer
HSMN NewsFeed,
20 Jun 2008:
Biopharmaceuticals, Personnel
[ArQule]
|
CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
HSMN NewsFeed,
18 Jun 2008:
Biopharmaceuticals, Oncology
[Cell Therapeutics, Bayer Schering Pharma, Zevalin]
|
MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System
HSMN NewsFeed,
17 Jun 2008:
Devices, Radiology, FDA
[MEDRAD, Fluorodeoxyglucose Infusion System, Intego System, imaging]
|
Lentigen Appoints Jim Meade as Vice President of Corporate Development
HSMN NewsFeed,
16 Jun 2008:
Biopharmaceuticals, Personnel
[Lentigen]
|
Indevus Announces Management Changes
HSMN NewsFeed,
12 Jun 2008:
Biopharmaceuticals, Personnel
[Indevus Pharmaceuticals]
|
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
HSMN NewsFeed,
10 Jun 2008:
Biopharmaceuticals, Personnel
[MDRNA, Nastech Pharmaceutical]
|
Indevus Pharmaceuticals Provides Update on NEBIDO(R) NDA Status
HSMN NewsFeed,
4 Jun 2008:
Biopharmaceuticals, FDA
[Indevus Pharmaceuticals, NEBIDO, testosterone]
|
Rivaroxaban Superior to U.S.-Approved Dosing Regimen for Enoxaparin in Reducing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial
HSMN NewsFeed,
30 May 2008:
Biopharmaceuticals, Orthopaedic, Surgery
[Johnson & Johnson, rivaroxaban, Enoxaparin, total knee]
|
ZymoGenetics Announces FDA Approval of RECOTHROM(TM) 20,000-IU Vial Size and Co-Packaging with Spray Kit
HSMN NewsFeed,
27 May 2008:
Biopharmaceuticals, FDA
[ZymoGenetics, RECOTHROM, Thrombin]
|
CyDex Pharmaceuticals Appoints Theron (Ted) Odlaug, Ph.D. as President and Chief Operating Officer
HSMN NewsFeed,
22 May 2008:
Biopharmaceuticals, Personnel
[Cydex Pharmaceuticals]
|
Innovative Biosensors, Inc. (IBI) Raises $11.5 Million
HSMN NewsFeed,
19 May 2008:
Diagnostics, Venture Capital
[Innovative Biosensors]
|
Bayer Announces Availability of Reformulated Liquid Leukine(R)
HSMN NewsFeed,
19 May 2008:
Biopharmaceuticals, FDA
[Bayer HealthCare, Leukine, sargramostim]
|
RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
HSMN NewsFeed,
19 May 2008:
Biopharmaceuticals, Oncology
[Novartis Pharmaceuticals, RECORD-1 trial, RAD001, mTOR, Kidney Cancer]
|
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
HSMN NewsFeed,
16 May 2008:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
HSMN NewsFeed,
8 May 2008:
Biopharmaceuticals, Ophthalmology
[Bayer HealthCare, Regeneron Pharmaceuticals, VIEW 2 trial, AMD , VEGF Trap-Eye]
|
Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
HSMN NewsFeed,
6 May 2008:
Biopharmaceuticals, Personnel
[Rib-X Pharmaceuticals]
|
ZymoGenetics Presents Positive Results from RECOTHROM(TM) Thrombin, topical (Recombinant) Spray Study in Burn Patients
HSMN NewsFeed,
30 Apr 2008:
Biopharmaceuticals, Wound Care
[ZymoGenetics, RECOTHROM, Thrombin]
|
Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests
HSMN NewsFeed,
30 Apr 2008:
Biopharmaceuticals, Personnel
[Titan Pharmaceuticals]
|
Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
HSMN NewsFeed,
28 Apr 2008:
Biopharmaceuticals, Ophthalmology
[Regeneron Pharmaceuticals, Bayer HealthCare, VEGF Trap-Eye, Macular Degeneration]
|
Veteran Drug Industry Executive to Become President of CTI
HSMN NewsFeed,
24 Apr 2008:
Biopharmaceuticals, Personnel
[Cell Therapeutics, Craig Philips]
|
Watson Files FDA Application for Generic YASMIN(R)
HSMN NewsFeed,
21 Apr 2008:
Biopharmaceuticals, Generics
[Watson Pharmaceuticals, Drospirenone, Ethinyl Estradiol, Bayer HealthCare]
|
Stiefel Laboratories Appoints First Chief Scientific Officer
HSMN NewsFeed,
7 Apr 2008:
Biopharmaceuticals, Dermatology, Personnel
[Stiefel Laboratories]
|
Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality
HSMN NewsFeed,
31 Mar 2008:
Devices, Personnel
[Cerus]
|
Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
HSMN NewsFeed,
26 Mar 2008:
Devices, Litigation
[Lumenis, Alma Lasers]
|
ARCALYST(TM) (rilonacept), First and Only FDA-approved Treatment for Cryopyrin-Associated Periodic Syndromes (CAPS), Now Available in the United States
HSMN NewsFeed,
25 Mar 2008:
Biopharmaceuticals
[Regeneron Pharmaceuticals, ARCALYST, rilonacept]
|
Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
HSMN NewsFeed,
13 Mar 2008:
Biopharmaceuticals, Personnel
[Juvaris BioTherapeutics]
|
Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
HSMN NewsFeed,
11 Mar 2008:
Biopharmaceuticals, Devices, Radiology
[Bayer HealthCare, RFID, VistaTrak, contrast media]
|
XOMA Appoints Mary L. Anderson as Vice President of Business Development
HSMN NewsFeed,
10 Mar 2008:
Biopharmaceuticals, Personnel
[XOMA]
|
Elusys Therapeutics Appoints Robert Gundel as Vice President of Research
HSMN NewsFeed,
10 Mar 2008:
Biopharmaceuticals, Personnel
[Elusys Therapeutics]
|
FDA Approves New Drug Application (NDA) for LEVOleucovorin, Spectrum's First Proprietary Oncology Drug
HSMN NewsFeed,
7 Mar 2008:
Biopharmaceuticals, Oncology, FDA
[Spectrum Pharmaceuticals, Levoleucovorin, methotrexate, leucovorin, osteosarcoma]
|
MEDRAD(R) Revenues Grow 10 Percent in 2007
HSMN NewsFeed,
4 Mar 2008:
Devices, Radiology
[MEDRAD, diagnostic imaging]
|
Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
HSMN NewsFeed,
4 Mar 2008:
Biopharmaceuticals, Licensing
[Juvaris BioTherapeutics, Bayer HealthCare]
|
Barr Announces Favorable Ruling in Yasmin(R) Patent Challenge
HSMN NewsFeed,
3 Mar 2008:
Biopharmaceuticals, Litigation
[Barr Pharmaceuticals, Bayer Schering, Yasmin, drospirenone, ethinyl estradiol]
|
Adnavance Technologies Inc. Appoints Anthony P. Bihl III to its Board of Directors
HSMN NewsFeed,
28 Feb 2008:
Diagnostics, Personnel
[Adnavance Technologies]
|
Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
HSMN NewsFeed,
28 Feb 2008:
Biopharmaceuticals, Oncology
[Novartis, Everolimus, RAD001, mTOR, kidney cancer]
|
FDA Approves Regeneron's ARCALYST(TM) (rilonacept) for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
HSMN NewsFeed,
27 Feb 2008:
Biopharmaceuticals, FDA
[Regeneron Pharmaceuticals, ARCALYST, rilonacept, Cryopyrin-Associated Periodic]
|
Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
HSMN NewsFeed,
26 Feb 2008:
Biopharmaceuticals, Personnel
[Onyx Pharmaceuticals]
|
Toshiba Names Girish T. Hagan as Vice President of Marketing
HSMN NewsFeed,
26 Feb 2008:
Devices, Personnel
[Toshiba America Medical Systems]
|
Bayer and Onyx Provide Update on Phase 3 Trial of Nexavar in Patients With Non-Small Cell Lung Cancer
HSMN NewsFeed,
18 Feb 2008:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Nexavar, sorafenib, NSCLC]
|
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
HSMN NewsFeed,
14 Feb 2008:
Biopharmaceuticals, Personnel
[BiPar Sciences]
|
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
HSMN NewsFeed,
12 Feb 2008:
Biopharmaceuticals
[Nektar Therapeutics]
|
Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
HSMN NewsFeed,
12 Feb 2008:
Biopharmaceuticals, Personnel
[Mersana Therapeutics]
|
Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
HSMN NewsFeed,
11 Feb 2008:
Devices, Mergers & Acquisitions
[Possis Medical, AngioJet, Bayer HealthCare, MEDRAD]
|
Two New Independent Directors Join Chelsea Therapeutics
HSMN NewsFeed,
8 Feb 2008:
Biopharmaceuticals, Personnel
[Chelsea Therapeutics]
|
Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals
[Indevus Pharmaceuticals, NEBIDO, testosterone undecanoate]
|
FDA Approves ZymoGenetics' RECOTHROM(TM) Thrombin, topical (Recombinant)
HSMN NewsFeed,
17 Jan 2008:
Biopharmaceuticals, FDA
[ZymoGenetics, Bayer HealthCare, RECOTHROM, rThrombin, Thromibin, hemostasis]
|
Shire Completes Fosrenol(R) Roll-Out in Major European Markets With Launch in Spain
HSMN NewsFeed,
17 Jan 2008:
Biopharmaceuticals
[Shire PLC, FOSRENOL, lanthanum, hyperphosphataemia, End Stage Renal Disease, CKD]
|
NOXXON Pharma appoints Dr. Frank Morich as Chief Executive Officer
HSMN NewsFeed,
7 Jan 2008:
Biopharmaceuticals, Personnel
[NOXXON Pharma]
|
Exelixis Announces Senior Management Promotions
HSMN NewsFeed,
4 Jan 2008:
Biopharmaceuticals, Personnel
[Exelixis]
|
Barnev, Inc. Names John Quigley Vice President, Marketing
HSMN NewsFeed,
2 Jan 2008:
Devices, Monitoring, Personnel
[Barnev, BirthTrack]
|
Echo Therapeutics Starts Clinical Study of Its Symphony(TM) Continuous Transdermal Glucose Monitoring System
HSMN NewsFeed,
2 Jan 2008:
Devices, Monitoring
[Echo Therapeutics, Symphony, Continuous Transdermal Glucose Monitoring, CTGM]
|
Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
HSMN NewsFeed,
27 Dec 2007:
Biopharmaceuticals, Acquisitions
[Cell Therapeutics, Biogen Idec, Zevalin, ibritumomab tiuxetan]
|
Marketing of Viadur(R) (leuprolide acetate implant) to Phase Out by April 2008
HSMN NewsFeed,
20 Dec 2007:
Biopharmaceuticals
[Bayer HealthCare Pharmaceuticals, Viadur, leuprolide acetate implant]
|
Nektar Promotes John Nicholson to Serve as Chief Financial Officer
HSMN NewsFeed,
11 Dec 2007:
Biopharmaceuticals, Personnel
[Nektar Therapeutics]
|
Pivotal Phase III Data Showed Rivaroxaban Was Statistically Superior to Enoxaparin in Preventing Venous Thromboembolism (VTE) in Patients Following Hip Replacement Surgery
HSMN NewsFeed,
8 Dec 2007:
[Johnson & Johnson, J&JPRD, rivaroxaban, anticoagulant, venous thromboembolism]
|
Biotest Pharmaceuticals Corporation Announces Management Team
HSMN NewsFeed,
4 Dec 2007:
Biopharmaceuticals, Personnel
[Biotest Pharmaceuticals]
|
Study Presented at RSNA Supports CADstream(R) for the Evaluation of Kinetics in Breast MRI
HSMN NewsFeed,
29 Nov 2007:
Devices, Radiology
[Confirma , CADstream, imaging]
|
Confirma Previews First Ever Prostate-Specific Computer-Aided-Detection (CAD) System for MRI and Introduces Next-Generation CAD for Breast MRI
HSMN NewsFeed,
27 Nov 2007:
Devices, Radiology
[Confirma , CADstream, Access Breast Coil, imaging]
|
MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
HSMN NewsFeed,
20 Nov 2007:
Devices, Radiology
[MEDRAD, Spectris Solaris EP, Mobile MR Injection System, imaging]
|
Confirma Expands Computer-Aided-Detection (CAD) for MRI to Prostate, Assisting in Improved Cancer Detection
HSMN NewsFeed,
20 Nov 2007:
Devices, Radiology, Oncology
[Confirma , CADstream, MRI]
|
Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
HSMN NewsFeed,
20 Nov 2007:
Biopharmaceuticals, Radiology, Group Purchasing
[Bayer HealthCare, MedAssets, Magnevist, gadopentetate dimeglumine, imaging agent]
|
Confirma to Showcase the Access Breast Coil(R) at RSNA in Chicago
HSMN NewsFeed,
19 Nov 2007:
Devices, Radiology
[Confirma , Access Breast Coil, CADstream, breast MRI, imaging]
|
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
HSMN NewsFeed,
19 Nov 2007:
Biopharmaceuticals, Oncology, FDA
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
Bayer HealthCare Pharmaceuticals, HealthTrust Purchasing Group Sign a Three-Year Renewal Agreement for Magnevist(R) Magnetic Resonance Contrast Media
HSMN NewsFeed,
8 Nov 2007:
Biopharmaceuticals, Radiology, Group Purchasing
[Bayer HealthCare Pharmaceuticals, HealthTrust Purchasing Group, Magnevist]
|
BRIGHT Results Show Less Pain and Higher Patient Satisfaction with Betaseron(R) than with Rebif(R)
HSMN NewsFeed,
7 Nov 2007:
Biopharmaceuticals, Neurology
[Bayer HealthCare, multiple sclerosis, Betaseron]
|
Watson Files FDA Application for Generic YAZ(R)
HSMN NewsFeed,
7 Nov 2007:
Biopharmaceuticals, Generics, FDA
[Watson Pharmaceuticals, YAZ, Bayer Schering Pharma, Bayer Healthcare]
|
Siemens Completes Acquisition of Dade Behring
HSMN NewsFeed,
6 Nov 2007:
Diagnostics, Mergers & Acquisitions
[Siemens Medical Solutions, Dade Behring]
|
Bayer Temporarily Suspends Global Trasylol(R) Marketing
HSMN NewsFeed,
5 Nov 2007:
Biopharmaceuticals
[Bayer HealthCare, Trasylol, aprotinin]
|
Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S.
HSMN NewsFeed,
2 Nov 2007:
Devices, Radiology, Oncology
[Siemens Medical Solutions, MAMMOMAT, NovationDR, digital mammography]
|
FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals, Endocrinology, FDA
[Indevus Pharmaceuticals, NEBIDO, testosterone, hypogonadism]
|
Nexavar Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals, Oncology, Regulatory
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
Savient Pharmaceuticals Announces Appointment of New VP Manufacturing
HSMN NewsFeed,
29 Oct 2007:
Biopharmaceuticals, Personnel
[Savient Pharmaceuticals]
|
Siemens Receives EU Antitrust Clearance for Acquisition of Dade Behring
HSMN NewsFeed,
25 Oct 2007:
Diagnostics, Mergers & Acquisitions
[Siemens Medical Solutions, Dade Behring]
|
Nektar Therapeutics Issues Statement on Exubera
HSMN NewsFeed,
18 Oct 2007:
Biopharmaceuticals, Endocrinology
[Nektar Therapeutics, Pfizer, Exubera , inhaled insulin, diabetes]
|
Neurogen Corporation Announces Appointment of Kenneth J. Sprenger to Vice President, Clinical Development and Operations
HSMN NewsFeed,
17 Oct 2007:
Biopharmaceuticals, Personnel
[Neurogen]
|
Cipher appoints William C. Garriock Chairman of the Board of Directors
HSMN NewsFeed,
16 Oct 2007:
Biopharmaceuticals, Personnel
[Cipher Pharmaceuticals]
|
Siemens Medical Solutions Diagnostics and Sysmex America, Inc. Extend Distribution Agreement
HSMN NewsFeed,
16 Oct 2007:
Diagnostics, Distribution
[Siemens Medical Solutions, Sysmex America, Urinalysis]
|
Isotechnika Inc. appoints two new senior company officers
HSMN NewsFeed,
10 Oct 2007:
Biopharmaceuticals, Personnel
[Isotechnika]
|
Optherion, Inc. Completes $37 Million Start Up Financing
HSMN NewsFeed,
9 Oct 2007:
Biopharmaceuticals, Ophthalmology, Venture Capital
[Optherion]
|
MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
HSMN NewsFeed,
4 Oct 2007:
Diagnostics, Group Purchasing
[Siemens Medical Solutions, MedAssets]
|
Onyx Pharmaceuticals Announces Management Changes
HSMN NewsFeed,
4 Oct 2007:
Biopharmaceuticals, Personnel
[Onyx Pharmaceuticals]
|
Good Imaging Now Comes in the World's Smallest Ultrasound Package
HSMN NewsFeed,
2 Oct 2007:
Devices
[Siemens Medical Solutions, ACUSON P10, ACUSON, ultrasound imaging]
|
Asphelia Pharmaceuticals Appoints Francois-Xavier Frapaise As President and Chief Executive Officer
HSMN NewsFeed,
27 Sep 2007:
Biopharmaceuticals, Personnel
[Asphelia Pharmaceuticals]
|
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel
[Titan Pharmaceuticals]
|
CuraGen Appoints Clinical Oncologist as VP of Medical Development
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals, Personnel
[CuraGen]
|
Phase 3 Pivotal Trial of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint
HSMN NewsFeed,
24 Sep 2007:
Biopharmaceuticals, Oncology
[Sonus Pharmaceuticals, TOCOSOL, Paclitaxel, metastatic breast cancer]
|
Nexavar Receives Positive Opinion from European Committee for Medicinal Products for Human Use for Treatment of Liver Cancer
HSMN NewsFeed,
21 Sep 2007:
Biopharmaceuticals, Oncology, Regulatory
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
HSMN NewsFeed,
20 Sep 2007:
Biopharmaceuticals, Oncology, FDA
[Genzyme, Bayer HealthCare, Campath, alemtuzumab, chronic lymphocytic leukemia]
|
CuraGen Corporation Announces Appointment of Dr. Timothy M. Shannon as President and Chief Executive Officer
HSMN NewsFeed,
19 Sep 2007:
Biopharmaceuticals, Personnel
[CuraGen]
|
PhotoMedex Hires Paul TanPiengco as Director of Marketing
HSMN NewsFeed,
18 Sep 2007:
Devices, Personnel
[PhotoMedex]
|
MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
HSMN NewsFeed,
18 Sep 2007:
Devices, Radiology
[MEDRAD, Prostate eCoil, Endorectal Coil, MRI]
|
FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
HSMN NewsFeed,
17 Sep 2007:
Biopharmaceuticals, Urology, FDA
[Ortho-McNeil, LEVAQUIN, levofloxacin, urinary tract infection]
|
FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
HSMN NewsFeed,
12 Sep 2007:
Biopharmaceuticals, FDA
[Bayer, Trasylol, aprotinin]
|
NCCN Updates Hepatobiliary Cancer Guidelines
HSMN NewsFeed,
11 Sep 2007:
Biopharmaceuticals, Oncology
[Onyx Pharmaceuticals, Bayer HealthCare, Nexavar, sorafenib, Hepatobiliary Cancer]
|
MEDRAD Introduces New Pressure-Rated Disposable for CT Power Injection
HSMN NewsFeed,
30 Aug 2007:
Devices
[MEDRAD, PRES Pressure-Rated Extension Set, power injection]
|
Siemens Medical Solutions to Distribute Candelis ImageGrid DICOM Archive Appliance for Flexible Storage Solution
HSMN NewsFeed,
30 Aug 2007:
Devices, Radiology
[Siemens Medical Solutions, Candelis, ImageGrid]
|
Indevus Announces Submission of New Drug Application
HSMN NewsFeed,
28 Aug 2007:
Biopharmaceuticals, Drug Delivery, FDA
[Indevus Pharmaceuticals, NEBIDO, testosterone undecanoate, hypogonadism]
|
Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
HSMN NewsFeed,
28 Aug 2007:
Diagnostics, Personnel
[Magellan Biosciences]
|
Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
HSMN NewsFeed,
27 Aug 2007:
Biopharmaceuticals
[Bristol-Myers Squibb, Pfizer, DGAT-1 inhibitors, DGAT- 1]
|
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
HSMN NewsFeed,
27 Aug 2007:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Oncology
[Regeneron Pharmaceuticals, sanofi-aventis, aflibercept, VEGF Trap]
|
Oscient Pharmaceuticals Names Aaron D. Berg Vice President of Marketing and Mark A. Glickman Vice President of Sales
HSMN NewsFeed,
23 Aug 2007:
Biopharmaceuticals, Personnel
[Oscient Pharmaceuticals]
|
Medtronic and Bayer Diabetes Care Announce Alliance to Provide Blood Glucose Meter to Medtronic Patients Outside the United States
HSMN NewsFeed,
21 Aug 2007:
Devices, Monitoring, Endocrinology
[Medtronic, Bayer HealthCare, diabetes, glucose monitor]
|
EPIX Pharmaceuticals Appoints Margaret Uprichard, Pharm.D. as Senior Vice President, Regulatory Affairs & Quality
HSMN NewsFeed,
21 Aug 2007:
Biopharmaceuticals, Personnel
[EPIX Pharmaceuticals]
|
Nexavar Granted FDA Priority Review for Treatment of Liver Cancer
HSMN NewsFeed,
20 Aug 2007:
Biopharmaceuticals, Oncology, FDA
[Onyx Pharmaceuticals, Bayer HealthCare, Nexavar, sorafenib, liver cancer]
|
Cell Therapeutics, Inc. (CTI) Enters Agreement to Acquire Lymphoma Drug Zevalin(R) from Biogen Idec for Sales and Marketing in the United States
HSMN NewsFeed,
16 Aug 2007:
Biopharmaceuticals, Acquisitions, Oncology
[Cell Therapeutics, Biogen Idec, Zevalin, ibritumomab tiuxetan, NHL]
|
Siemens Medical Solutions Executives Assume New Industry Leadership Roles and Key Appointments
HSMN NewsFeed,
9 Aug 2007:
Devices, Personnel
[Siemens Medical Solutions]
|
Rilonacept (IL-1 Trap) Granted FDA Priority Review for the Treatment of CAPS
HSMN NewsFeed,
8 Aug 2007:
Biopharmaceuticals
[Regeneron Pharmaceuticals, rilonacept, Interleukin-1 trap]
|
Siemens syngo(R) Colonography PEV for CT Colonography Examinations - A New Level of Effectiveness
HSMN NewsFeed,
7 Aug 2007:
Devices, Radiology
[Siemens Medical Solutions, CT colonography, syngo , Colonography PEV]
|
KineMed and Merck Enter Collaboration in Atherosclerosis
HSMN NewsFeed,
7 Aug 2007:
Biopharmaceuticals
[KineMed, Merck]
|
Bayer HealthCare and Nektar Therapeutics Launch Global Development and Commercialization Agreement to Fight Gram-Negative Pneumonias
HSMN NewsFeed,
6 Aug 2007:
Biopharmaceuticals, Drug Delivery
[Nektar Therapeutics, Bayer HealthCare, NKTR-061, amikacin, antibiotic, pneumonia]
|
Regeneron and Bayer HealthCare Initiate Phase 3 Global Development Program For VEGF Trap-Eye In Wet Age-Related Macular Degeneration (AMD)
HSMN NewsFeed,
2 Aug 2007:
Biopharmaceuticals, Ophthalmology
[Regeneron Pharmaceuticals, Bayer HealthCare, VEGF Trap]
|
Hollis-Eden Pharmaceuticals Names Scott M. Freeman, M.D., Chief Medical Officer
HSMN NewsFeed,
2 Aug 2007:
Biopharmaceuticals, Personnel
[Hollis-Eden Pharmaceuticals]
|
Dade Behring Announces Agreement to Be Acquired by Siemens
HSMN NewsFeed,
25 Jul 2007:
Diagnostics, Mergers & Acquisitions
[Dade Behring, Siemens Medical Solutions]
|
MEDRAD(R) Announces New Head of Corporate Services
HSMN NewsFeed,
23 Jul 2007:
Devices, Radiology, Personnel
[MEDRAD]
|
MEDRAD(R) Announces New Head of Magnetic Resonance Business Unit
HSMN NewsFeed,
23 Jul 2007:
Devices, Radiology, Personnel
[MEDRAD, Magnetic Resonance]
|
Premier Extends Agreement With Bayer HealthCare Pharmaceuticals
HSMN NewsFeed,
23 Jul 2007:
Biopharmaceuticals, Radiology, Group Purchasing
[Bayer HealthCare, Premier Purchasing, Magnevist, gadopentetate dimeglumine]
|
Novation Awards Agreement to Siemens Medical Solutions Diagnostics to Provide Portfolio of Chemistry, Immunochemistry and Automation Solutions
HSMN NewsFeed,
19 Jul 2007:
Diagnostics, Group Purchasing
[Siemens Medical Solutions, Novation]
|
Siemens Medical Solutions Diagnostics Announces Enhanced Liver Fibrosis Test for Europe
HSMN NewsFeed,
18 Jul 2007:
Diagnostics, Regulatory
[Siemens Medical Solutions, Enhanced Liver Fibrosis test, Fibrosis]
|
Premier Awards MEDRAD Two-Year Contract Extension for Vascular Injection Systems
HSMN NewsFeed,
16 Jul 2007:
Devices, Radiology, Group Purchasing
[MEDRAD, Premier Purchasing, vascular injection, imaging]
|
MEDRAD Introduces New Extravasation Detector Technology
HSMN NewsFeed,
10 Jul 2007:
Devices, Radiology
[MEDRAD, Extravasation Detector, MEDRAD XDS, Stellant]
|
Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
HSMN NewsFeed,
8 Jul 2007:
Biopharmaceuticals
[Johnson & Johnson, venous thromboembolism, Factor Xa, rivaroxaban, knee]
|
Bayer HealthCare Announces New 2000 IU Vial Size for Kogenate(R) FS Treatments
HSMN NewsFeed,
29 Jun 2007:
Biopharmaceuticals
[Bayer HealthCare, Kogenate FS, Antihemophilic Factor]
|
Titan Annnounces Completion of Patient Enrollment in Randomized Phase IIb Clinical Study of Spheramine(R) In Parkinson's Disease
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Neurology
[Titan Pharmaceuticals, Spheramine, Parkinson's disease]
|
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
HSMN NewsFeed,
27 Jun 2007:
Biopharmaceuticals, Oncology
[Bayer HealthCare Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
HSMN NewsFeed,
26 Jun 2007:
Biopharmaceuticals
[Nuvelo, Bayer HealthCare, alfimeprase, fibrinolytic, stroke]
|
Actavis Launches Generic Adalat(R) CC Tablets in the U.S.
HSMN NewsFeed,
26 Jun 2007:
Biopharmaceuticals, Generics
[Actavis, Nifedipine, Adalat, Bayer Healthcare]
|
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Radiology
[Avid Radiopharmaceuticals, Bayer Schering Pharma, 18F-AV1/ZK, imaging]
|
Bayer and Onyx Submit New European Marketing Authorization Application to EMEA for Nexavar to Treat Liver Cancer
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Oncology, Regulatory
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
Memory Pharmaceuticals Establishes Plans for Clinical Program for MEM 3454 in Schizophrenia
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Neurology
[Memory Pharmaceuticals, MEM 3454, Schizophrenia]
|
ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Licensing
[ZymoGenetics, Bayer HealthCare, recombinant human thrombin, rThrombin]
|
Confirma Appoints New Vice President of Sales
HSMN NewsFeed,
18 Jun 2007:
Devices, Radiology, Oncology, Personnel
[Confirma , CADstream, computer-aided detection]
|
Siemens Demonstrates New Methods of Cardiovascular Risk Assessment at the American Society of Echocardiography
HSMN NewsFeed,
16 Jun 2007:
Devices, Cardiology
[Siemens Medical Solutions, syngo , ACUSON]
|
Siemens Offers Exclusive First Look at How Dual Source CT is Turning Dual Energy into Clinical Routine at the Stanford Symposium on Multidetector-Row CT
HSMN NewsFeed,
15 Jun 2007:
Devices, Radiology
[Siemens Medical Solutions, syngo , Dual Energy, Computed Tomography]
|
Seattle Genetics Adds Industry Veterans John P. McLaughlin and Daniel G. Welch to its Board of Directors and Promotes Eric Dobmeier to Chief Business Officer
HSMN NewsFeed,
14 Jun 2007:
Biopharmaceuticals, Oncology, Personnel
[Seattle Genetics]
|
Schering-Plough and Bayer Healthcare Announce Availability of ZETIA in Japan, the First Cholesterol-Lowering Agent With a Novel Mechanism of Action Approved in Japan in 18 Years
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals, Regulatory
[Schering-Plough, Bayer HealthCare, ZETIA, ezetimibe, hypercholesterolemia]
|
Regeneron Submits Biologics License Application to U.S. FDA for IL-1 Trap (Rilonacept) for Treatment of CAPS
HSMN NewsFeed,
8 Jun 2007:
Biopharmaceuticals
[Regeneron Pharmaceuticals, Interleukin-1 Trap, rilonacept]
|
Indevus Reports Positive Data From Phase III NEBIDO(R) Trial
HSMN NewsFeed,
7 Jun 2007:
Biopharmaceuticals
[Indevus Pharmaceuticals, NEBIDO, testosterone undecanoate]
|
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
HSMN NewsFeed,
6 Jun 2007:
Biopharmaceuticals, Oncology
[Abbott, Caprion Proteomics, Thallion Pharmaceuticals, CellCarta]
|
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Personnel
[Avid Radiopharmaceuticals]
|
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
Resolution Revolution: Siemens Unveils World's First High Definition PET-CT, Providing Unprecedented Clarity Through Entire Field of View
HSMN NewsFeed,
3 Jun 2007:
Devices, Radiology, Oncology
[Siemens Medical Solutions, Biograph , HD-PET, PET-CT]
|
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology
[Xanthus Pharmaceuticals, Bayer Schering Pharma, P2045, NSCLC]
|
Rob Frankenberg, Ph.D. Joins Bionovo as Vice President of Drug Manufacturing
HSMN NewsFeed,
31 May 2007:
Biopharmaceuticals, Personnel
[Bionovo]
|
Siemens Demonstrates World's First System Capable of Simultaneous Imaging of the Brain by MRI and PET
HSMN NewsFeed,
21 May 2007:
Devices, Radiology
[Siemens Medical Solutions, PET , MRI, MR-PET, imaging]
|
Milestone Scientific Forms New Medical Division and Appoints Former Bayer Senior Executive as Its CEO
HSMN NewsFeed,
21 May 2007:
Devices, Drug Delivery, Personnel
[Milestone Scientific]
|
Ciphergen Appoints Steve Lundy as Senior Vice President of Sales and Marketing
HSMN NewsFeed,
15 May 2007:
Diagnostics, Personnel
[Ciphergen Biosystems]
|
Spiration, Inc. Names Nancy Hill Vice President, Marketing to Strengthen Market Development and Global Product Commercialization Initiatives
HSMN NewsFeed,
9 May 2007:
Devices, Personnel
[ Spiration]
|
Avid Radiopharmaceuticals Closes $26 Million Series C Financing
HSMN NewsFeed,
9 May 2007:
Biopharmaceuticals, Radiology, Neurology, Venture Capital
[Avid Radiopharmaceuticals]
|
VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
HSMN NewsFeed,
9 May 2007:
Biopharmaceuticals, Ophthalmology
[Regeneron Pharmaceuticals, VEGF Trap, macular degeneration, macular edema]
|
Siemens Medical Solutions Revolutionizes Electrophysiology With syngo(R) DynaCT Cardiac
HSMN NewsFeed,
9 May 2007:
Devices, Cardiology
[Siemens Medical Solutions, syngo , DynaCT, cardiac imaging, electrophysiology]
|
Bayer HealthCare and Intendis Announce Strategic Alliance to Co-Promote Yaz(R) (Drospirenone/Ethinyl Estradiol) for Treatment of Moderate Acne
HSMN NewsFeed,
7 May 2007:
Biopharmaceuticals, Dermatology
[Bayer HealthCare, Intendis, Bayer Schering, YAZ , drospirenone, estradiol]
|
Siemens Introduces ACUSON Antares 5.0 Release and Spotlights ACUSON X150 Ultrasound System
HSMN NewsFeed,
4 May 2007:
Devices, Radiology
[Siemens Medical Solutions, ACUSON Antares, ultrasound]
|
Studies Presented at Neurology Conference Highlight Early Efficacy, Long-Term Tolerability, and High Patient Satisfaction with Betaseron(R)
HSMN NewsFeed,
3 May 2007:
Biopharmaceuticals, Neurology
[Bayer HealthCare, Betaseron, interferon beta-1b, multiple sclerosis]
|
Barr Receives Approval for Generic Nimotop(R) Capsules, 30 mg
HSMN NewsFeed,
2 May 2007:
Biopharmaceuticals, Generics, FDA
[Barr Pharmaceuticals, nimodipine, Bayer, Nimotop]
|
Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
HSMN NewsFeed,
2 May 2007:
Biopharmaceuticals, Neurology
[Genzyme, Bayer HealthCare, alemtuzumab, Rebif , multiple sclerosis]
|
First of Its Kind Data Show: Immediate Treatment of Early MS Patients with Betaseron(R) Significantly Delayed Permanent Disability
HSMN NewsFeed,
1 May 2007:
Biopharmaceuticals, Neurology
[Bayer HealthCare, Betaseron, interferon beta-1b, multiple sclerosis]
|
Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Nimotop(R)
HSMN NewsFeed,
27 Apr 2007:
Biopharmaceuticals, Cardiology, Generics
[Caraco Pharmaceutical Laboratories, Nimodipine, Nimotop, Bayer Pharmaceuticals]
|
Merck KGaA and WHO Conclude Partnership to Control Schistosomiasis in Africa
HSMN NewsFeed,
19 Apr 2007:
Biopharmaceuticals
[Merck KGaA, Cesol 600, praziquantel, Schistosomiasis]
|
Schering-Plough Announces ZETIA Approved in Japan for Treatment of High Cholesterol
HSMN NewsFeed,
18 Apr 2007:
Biopharmaceuticals, Regulatory
[Schering-Plough, Schering-Plough K.K., ZETIA, ezetimibe]
|
350th Installed MAGNETOM Trio Demonstrates the Clinical Need for High-Field MRI
HSMN NewsFeed,
16 Apr 2007:
Devices, Radiology
[Siemens Medical Solutions, 3T , MAGNETOM Trio, magnetic resonance imaging]
|
Premier Inc. Picks Siemens Medical Solutions Diagnostics to Provide Integrated and Urinalysis Solutions
HSMN NewsFeed,
9 Apr 2007:
Diagnostics, Group Purchasing
[Siemens Medical Solutions, Premier Purchasing]
|
Bayer Healthcare Pharmaceuticals Officially Launches in the United States
HSMN NewsFeed,
4 Apr 2007:
Biopharmaceuticals, Mergers & Acquisitions
[Bayer HealthCare, Berlex, Schering AG]
|
EPIX Provides Update Regarding Status of Vasovist(TM) Appeal
HSMN NewsFeed,
2 Apr 2007:
Biopharmaceuticals, Radiology, FDA
[EPIX Pharmaceuticals, Vasovist, gadofosveset, imaging agent]
|
Dong-A PharmTech Co., Ltd. Announces Positive Results for Udenafil, Its New Long Acting Drug For Erectile Dysfunction
HSMN NewsFeed,
28 Mar 2007:
Biopharmaceuticals
[Dong-A PharmTech, udenafil, erectile dysfunction]
|
Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
HSMN NewsFeed,
27 Mar 2007:
Biopharmaceuticals
[Seattle Genetics, Genentech]
|
Siemens Medical Solutions Diagnostics' Clinitek Advantus Analyzer Delivers the Next Generation of Urinalysis Testing Technology
HSMN NewsFeed,
26 Mar 2007:
Diagnostics, Devices
[Siemens Medical Solutions, Clinitek, Urinalysis]
|
Indevus Reports That Interim Review of NEBIDO(R) Phase III Data Indicates Trial Is Likely to Meet Primary Endpoints
HSMN NewsFeed,
26 Mar 2007:
Biopharmaceuticals, Endocrinology
[Indevus Pharmaceuticals, testosterone undecanoate, testosterone]
|
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
HSMN NewsFeed,
26 Mar 2007:
Biopharmaceuticals, Generics, FDA
[Mylan Laboratories, Ciprofloxacin ER, Bayer Pharmaceuticals, Cipro XR]
|
A 2-in-1 Solution: Siemens' Latest in Hemo/EP Recording Solutions Provides New Levels of Flexibility to Manage Increasing Demands of Catheterization Labs
HSMN NewsFeed,
25 Mar 2007:
Devices, Cardiology
[Siemens Medical Solutions, hemodynamics, electrophysiology]
|
Seattle Genetics Appoints Dr. Tom Reynolds Chief Medical Officer
HSMN NewsFeed,
20 Mar 2007:
Biopharmaceuticals, Personnel
[Seattle Genetics]
|
Anthera Pharmaceuticals, Inc. Announces Appointment of Dr. James Pennington as Executive Vice President & Chief Medical Officer
HSMN NewsFeed,
20 Mar 2007:
Biopharmaceuticals, Personnel
[Anthera Pharmaceuticals]
|
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed,
19 Mar 2007:
Biopharmaceuticals, Radiology, Neurology
[Avid Radiopharmaceuticals, AV-1, Alzheimer's disease, ß-amyloid, imaging]
|
Introducing New ALEVE(R) Liquid Gels
HSMN NewsFeed,
13 Mar 2007:
Biopharmaceuticals
[Bayer HealthCare, ALEVE, naproxen]
|
Siemens Completes Acquisition of the BD.id(TM) System for Patient Identification and Specimen Management
HSMN NewsFeed,
8 Mar 2007:
Devices, Acquisitions
[Siemens Medical Solutions, BD , BD.id]
|
U.S. Patent Board Awards Enzo Biochem Judgment in Patent Interference after Princeton University Concedes Priority
HSMN NewsFeed,
7 Mar 2007:
Diagnostics
[Enzo Biochem, Chiron, Bayer HealthCare, nucleic acid signal amplification]
|
Perrigo Company to Acquire Qualis, Inc.
HSMN NewsFeed,
7 Mar 2007:
Biopharmaceuticals, Mergers & Acquisitions
[Perrigo Company, Qualis]
|
UK Launch Expands Global Reach of FOSRENOL(R)
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals
[Shire PLC, FOSRENOL, lanthanum, hyperphosphataemia]
|
IRIS Appoints Thomas E. Warekois as President of Iris Diagnostics Business Unit
HSMN NewsFeed,
5 Mar 2007:
Diagnostics, Personnel
[IRIS International]
|
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
HSMN NewsFeed,
5 Mar 2007:
Biopharmaceuticals, Radiology, Neurology
[Siemens Medical Solutions, Wyeth, Alzheimer's disease, PET molecular imaging]
|
Study Confirms That Significant Insulin Dose Errors Can Result When Blood Glucose Meters are Miscoded
HSMN NewsFeed,
1 Mar 2007:
Devices, Monitoring, Endocrinology
[Bayer HealthCare, Metrika, blood glucose monitor]
|
EPIX Pharmaceuticals Files Formal Appeal for Vasovist(TM) with the Center for Drug Evaluation and Research
HSMN NewsFeed,
28 Feb 2007:
Biopharmaceuticals, FDA
[EPIX Pharmaceuticals, Vasovist, gadofosveset]
|
Favrille Announces Agreement With Berlex, Inc. Regarding Use of FavId(R) in Combination With Leukine(R) (sargramostim) in B-Cell Non-Hodgkin's Lymphoma
HSMN NewsFeed,
14 Feb 2007:
Biopharmaceuticals, Oncology
[Favrille, Berlex, FavId, Leukine, non-Hodgkin's lymphoma]
|
Seattle Genetics Receives Orphan Drug Designations for its SGN-33 and SGN-35 Programs
HSMN NewsFeed,
13 Feb 2007:
Biopharmaceuticals, FDA
[Seattle Genetics, orphan drug designation, SGN-33, SGN-35]
|
Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
HSMN NewsFeed,
12 Feb 2007:
Biopharmaceuticals, Oncology
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, liver cancer, Nexavar, sorafenib]
|
Siemens Medical Solutions Settles Charges Regarding Cook County Hospital Bid
HSMN NewsFeed,
8 Feb 2007:
Devices, Radiology, Litigation
[Siemens Medical Solutions]
|
EPIX Pharmaceuticals Presents Data from Novel MRI Imaging Agent at the Society for Cardiovascular Magnetic Resonance Meeting
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals, Radiology, Cardiology
[EPIX Pharmaceuticals, EP-3533, gadolinium, magnetic resonance imaging]
|
AstraZeneca Licenses Regeneron's VelocImmune(R) Technology for Discovering Human Monoclonal Antibodies
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals, Licensing
[Regeneron Pharmaceuticals, AstraZeneca]
|
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
HSMN NewsFeed,
5 Feb 2007:
Diagnostics, Personnel
[Sequenom]
|
CSL Behring and Bayer Extend Agreement for Supply of Helixate(R) Recombinant Coagulation Factor
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals, Licensing, Distribution
[CSL Behring, Bayer HealthCare, Helixate, Factor VIII]
|
VioQuest Pharmaceuticals, Inc. Announces Appointment of Chief Scientific Officer
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals, Personnel
[VioQuest Pharmaceuticals]
|
Bio-Rad and Siemens Medical Solutions Diagnostics Enter Into Joint Marketing Agreement to Offer Products to Optimize Clinical Laboratory Test Systems
HSMN NewsFeed,
31 Jan 2007:
Diagnostics
[Bio-Rad Laboratories, Siemens Medical Solutions]
|
FDA Approves New Indication for YAZ(R) to Treat Acne
HSMN NewsFeed,
29 Jan 2007:
Biopharmaceuticals, Dermatology, FDA
[Berlex, YAZ , acne vulgaris, oral contraceptive]
|
Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
HSMN NewsFeed,
25 Jan 2007:
Biopharmaceuticals
[Bayer HealthCare, Trasylol, aprotinin]
|
Synta Pharmaceuticals Corp. Announces Additions to Senior Management Team
HSMN NewsFeed,
23 Jan 2007:
Biopharmaceuticals, Personnel
[Synta Pharmaceuticals]
|
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
HSMN NewsFeed,
19 Jan 2007:
Biopharmaceuticals, Radiology, Licensing
[Bayer Schering Pharma, Taisho Pharmaceutical, Nihon Nohyaku, imaging]
|
Siemens Medical Solutions and Biosense Webster Extend Strategic Alliance for Siemens' AcuNav Catheters
HSMN NewsFeed,
18 Jan 2007:
Devices, Cardiology, Distribution
[Siemens Medical Solutions, Biosense Webster, ACUSON, AcuNav, ultrasound catheter]
|
Neuroptix Expands Executive Team, Adds Evan Sherr as Vice President, Product Management, and Vincent Valvo as Vice President, Engineering and Product Development
HSMN NewsFeed,
18 Jan 2007:
Devices, Diagnostics, Personnel
[Neuroptix]
|
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate from Bayer Schering Pharma
HSMN NewsFeed,
17 Jan 2007:
Biopharmaceuticals, Oncology, Licensing
[Molecular Insight Pharmaceuticals, Bayer Schering, Solazed]
|
Bayer and Onyx Announce Pivotal Nexavar(R) Kidney Cancer Study Published in New England Journal of Medicine
HSMN NewsFeed,
10 Jan 2007:
Biopharmaceuticals, Oncology
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib, kidney cancer]
|
NCCN Updates Antiemesis Guidelines
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Oncology
[NCCN, Antiemesis Guidelines]
|
Genentech and Seattle Genetics Announce Exclusive Global Licensing Agreement for Development and Commercialization of SGN-40
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Oncology, Licensing
[Seattle Genetics, Genentech, SGN-40]
|
Seattle Genetics and Agensys Announce Collaboration to Co-Develop and Commercialize Antibody-Drug Conjugate Therapies for Cancer
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Licensing
[Seattle Genetics, Agensys]
|
Court Affirms $7 Million in Damages for Innogenetics in Patent Infringement Suit
HSMN NewsFeed,
4 Jan 2007:
Biopharmaceuticals, Diagnostics, Litigation
[Innogenetics, Abbott]
|
Aerovance Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
HSMN NewsFeed,
3 Jan 2007:
Biopharmaceuticals
[Aerovance, AEROVANT, asthma]
|
Acquisition of Bayer's Diagnostic Division Finalized
HSMN NewsFeed,
3 Jan 2007:
Diagnostics, Mergers & Acquisitions
[Siemens AG, Siemens Medical Solutions, Bayer Diagnostics]
|
Regeneron Reports Blocking New Angiogenesis Target May Offer Novel Approach to Slowing Tumor Growth
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals, Oncology
[Regeneron Pharmaceuticals, Dll4, angiogenesis]
|
Bayer Pharmaceuticals Corporation Informs Health Care Professionals of Important Safety Revisions to the Trasylol Label
HSMN NewsFeed,
15 Dec 2006:
Biopharmaceuticals
[Bayer Pharmaceuticals, Trasylol, aprotinin]
|
Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada
HSMN NewsFeed,
12 Dec 2006:
Biopharmaceuticals, Distribution
[Auxilium Pharmaceuticals, Paladin Labs, Testim , testosterone gel]
|
Advanced Life Sciences Announces Election of Theron (Ted) E. Odlaug, Ph.D. to Its Board of Directors
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals, Personnel
[Advanced Life Sciences]
|
Memory Pharmaceuticals Announces Release of Clinical Hold on MEM 3454
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals, Neurology
[Memory Pharmaceuticals, MEM 3454, Alzheimer's disease]
|
Nuvelo and Bayer Healthcare Announce Phase 3 Trials of Alfimeprase in Patients With Acute Peripheral Arterial Occlusion and Catheter Occlusion Did Not Meet Primary Endpoints
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals
[Nuvelo, Bayer HealthCare, alfimeprase, peripheral arterial occlusion, NAPA-2]
|
Phase III Trial of Nexavar in Patients with Advanced Melanoma Does Not Meet Primary Endpoint
HSMN NewsFeed,
4 Dec 2006:
Biopharmaceuticals, Oncology
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Adnexus Therapeutics Appoints Bruce A. Silver, MD, FACP as Medical Director
HSMN NewsFeed,
28 Nov 2006:
Biopharmaceuticals, Oncology, Personnel
[Adnexus Therapeutics]
|
Schering-Plough Appoints Thierry Powis President Director, Indonesia
HSMN NewsFeed,
27 Nov 2006:
Biopharmaceuticals, Personnel
[Schering-Plough]
|
Betaferon(R) Approved in Australia for Earliest Stages of Multiple Sclerosis
HSMN NewsFeed,
23 Nov 2006:
Biopharmaceuticals, Regulatory, Neurology
[Schering AG, Bayer Group, Betaferon, interferon beta-1b, multiple sclerosis]
|
New Analyses Demonstrate Positive Effect on Bone With Fosrenol(R) Treatment Compared With Standard Therapy
HSMN NewsFeed,
20 Nov 2006:
Biopharmaceuticals
[Shire plc, FOSRENOL, Lanthanum]
|
Bayer Outlines New Global R&D Structures; U.S. Pharma Sites and Future Headquarters
HSMN NewsFeed,
9 Nov 2006:
Biopharmaceuticals
[Bayer HealthCare, Schering AG]
|
Go-Ahead for Schering's Integration Into the Bayer Group
HSMN NewsFeed,
8 Nov 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Schering AG, Bayer , Bayer Schering, Dritte BV GmbH]
|
Significant Errors In Insulin Dose Can Result When Blood Glucose Meters Are Miscoded According to New Clinical Study
HSMN NewsFeed,
6 Nov 2006:
Devices, Diagnostics, Monitoring, Endocrinology
[Bayer HealthCare, glucose monitor, diabetes]
|
NovaDel Pharma Receives FDA Approval of NitroMist(TM)
HSMN NewsFeed,
3 Nov 2006:
Biopharmaceuticals, Drug Delivery, FDA, Cardiology
[NovaDel Pharma, NitroMis, Nitroglycerin Lingual Aerosol, angina]
|
Newly-Published Data Showed LEVITRA(R) Treated Erectile Dysfunction Effectively at First Dose In Men With Certain Associated Cardiovascular Conditions
HSMN NewsFeed,
3 Nov 2006:
Biopharmaceuticals
[Schering-Plough, GlaxoSmithKline, LEVITRA, vardenafil]
|
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
HSMN NewsFeed,
18 Oct 2006:
Biopharmaceuticals, Ophthalmology
[Bayer HealthCare, Regeneron Pharmaceuticals, VEGF Trap, macular degeneration]
|
Bayer Appoints Independent Investigator to Review Trasylol(R) Study Issues
HSMN NewsFeed,
13 Oct 2006:
Biopharmaceuticals
[Bayer HealthCare, Trasylol]
|
KaloBios Pharmaceuticals Appoints David W. Pritchard as President and Chief Executive Officer
HSMN NewsFeed,
12 Oct 2006:
Biopharmaceuticals, Personnel
[KaloBios Pharmaceuticals]
|
Penwest Names Dr. Amy O'Donnell Senior Director, Clinical Development
HSMN NewsFeed,
5 Oct 2006:
Biopharmaceuticals, Personnel
[Penwest Pharmaceuticals]
|
Archemix Strengthens Management With Appointment of James Gilbert, M.D., as Chief Medical Officer
HSMN NewsFeed,
3 Oct 2006:
Biopharmaceuticals, Personnel
[Archemix]
|
Bayer Acknowledges That New Trasylol Study Was Not Disclosed Prior to Recent FDA Cardio-Renal Advisory Committee Meeting
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals, Cardiology, FDA
[Bayer Healthcare, aprotinin, aminocaproic acid, tranexamic acid]
|
Efficacy of Once-Daily AVELOX(R) in Treating Complicated Intra-Abdominal Infections Highlighted in Two Clinical Data Presentations at ICAAC
HSMN NewsFeed,
29 Sep 2006:
Biopharmaceuticals
[Schering-Plough, AVELOX, moxifloxacin, complicated intra-abdominal infections]
|
FDA Advisory Committee Strongly Endorses Use of Trasylol(R) in CABG Surgery Patients
HSMN NewsFeed,
21 Sep 2006:
Biopharmaceuticals, Cardiology, FDA
[Bayer HealthCare, Trasylol, aprotinin, coronary artery bypass graft]
|
Baxter Names Peter Nicklin Corporate Vice President and President, Baxter Europe
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Devices, Personnel
[Baxter, Peter Nicklin]
|
Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R)
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals
[Talecris Biotherapeutics, Prolastin]
|
Nuvelo Announces Completion of Patient Enrollment in SONOMA-2, First Phase 3 Trial of Alfimeprase in Central Venous Catheter Occlusion
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals
[Nuvelo, alfimeprase, central venous catheter occlusion, SONOMA-2]
|
Nuvelo Announces Completion of Patient Enrollment in NAPA-2, First Phase 3 Trial of Alfimeprase in Acute Peripheral Arterial Occlusion
HSMN NewsFeed,
5 Sep 2006:
Biopharmaceuticals
[Nuvelo, alfimeprase, peripheral arterial occlusion, leg attack, NAPA-2]
|
Bausch & Lomb Licenses rPlasmin from Talecris Biotherapeutics for Ophthalmic Use
HSMN NewsFeed,
29 Aug 2006:
Biopharmaceuticals, Ophthalmology, Licensing
[Bausch & Lomb, Talecris Biotherapeutics, recombinant Plasmin]
|
Bayer Diagnostics Launches ADVIA Centaur(R) XP Immunoassay System
HSMN NewsFeed,
28 Aug 2006:
Diagnostics
[Bayer HealthCare, ADVIA Centaur, Immunoassay]
|
Delcath Systems Appoints Dr. Seymour Fein as New Chief Scientific Officer
HSMN NewsFeed,
21 Aug 2006:
Devices, Personnel
[Delcath Systems]
|
Kosan Appoints Gary Titus Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
15 Aug 2006:
Biopharmaceuticals, Personnel
[Kosan Biosciences]
|
Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/ml
HSMN NewsFeed,
31 Jul 2006:
Biopharmaceuticals, Radiology, Product Recall
[Schering AG, Berlex, Ultravist, iopromide, imaging]
|
Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) Injection 370 mgI/ml Recall and Insufficient Results of Clinical Phase III Trial With Sargramostim (n.o.v.e.l. 4)
HSMN NewsFeed,
31 Jul 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Schering AG, Bayer]
|
Alcon's VEGAMOX(TM) Ophthalmic Solution Approved in Japan for Eye Infections
HSMN NewsFeed,
26 Jul 2006:
Biopharmaceuticals, Ophthalmology, Regulatory
[Alcon , VEGAMOX, moxifloxacin]
|
Study Shows Once-Daily AVELOX(R) as Effective as Multi-Dose Combination Therapy in Treating Complicated Intra-Abdominal Infections
HSMN NewsFeed,
25 Jul 2006:
Biopharmaceuticals
[Schering-Plough, AVELOX, moxifloxacin, cIAI]
|
Nexavar(R) Approved by European Commission for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed,
23 Jul 2006:
Biopharmaceuticals, Oncology, Regulatory
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Bayer HealthCare Introduces Free Product Trial Program For Kogenate(R) FS with BIO-SET(R)
HSMN NewsFeed,
17 Jul 2006:
Biopharmaceuticals
[Bayer HealthCare, Kogenate FS, hemophilia]
|
Aileen Ryan Joins Vion Pharmaceuticals' Senior Management Team
HSMN NewsFeed,
17 Jul 2006:
Biopharmaceuticals
[Vion Pharmaceuticals]
|
EPIX Pharmaceuticals Retains Full Rights to Fibrin-Binding Imaging Agent EP-2104R as Schering AG Decides Not to Exercise Option for Development Program
HSMN NewsFeed,
13 Jul 2006:
Biopharmaceuticals, Radiology
[EPIX Pharmaceuticals, Predix Pharmaceuticals, Schering AG, EP-2104R]
|
Cambridge Heart Appoints New Vice President
HSMN NewsFeed,
10 Jul 2006:
Diagnostics, Cardiology, Personnel
[Cambridge Heart, Mark Florence, Microvolt T-Wave Alternans]
|
Bayer Acquires Metrika Inc.
HSMN NewsFeed,
6 Jul 2006:
Devices, Diagnostics, Mergers & Acquisitions
[Bayer HealthCare, Metrika, A1CNow+, diabetes]
|
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
HSMN NewsFeed,
6 Jul 2006:
Biopharmaceuticals
[ Nuvelo, alfimeprase, Cathflo, Activase, alteplase, catheter occlusion]
|
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
HSMN NewsFeed,
29 Jun 2006:
Biopharmaceuticals, Personnel
[Nuvelo]
|
Gen-Probe, Bayer Agree to Settle Patent Disputes
HSMN NewsFeed,
22 Jun 2006:
Diagnostics, Litigation
[Gen-Probe, Bayer HealthCare]
|
Bayer Diagnostics Receives FDA Approval for First Fully-Automated Human Immunodeficiency Virus (HIV) Antibody Test
HSMN NewsFeed,
21 Jun 2006:
Diagnostics, HIV/AIDS, FDA
[Bayer HealthCare, ADVIA Centaur, Immunoassay System]
|
Cellegy Pharmaceuticals Appoints Agis to Distribute Rectogesic(R) in Israel
HSMN NewsFeed,
20 Jun 2006:
Biopharmaceuticals, Distribution
[Cellegy Pharmaceuticals, Agis Commercial Agencies, Rectogesic]
|
Daxor Announces Addition to Board of Directors and Appointment of New Vice President of Engineering
HSMN NewsFeed,
15 Jun 2006:
Devices, Diagnostics, Personnel
[Daxor]
|
Merck Offers Bayer Its Stake in Schering
HSMN NewsFeed,
14 Jun 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Bayer, Merck, Schering]
|
Pfizer Enters Into Agreement with Bayer to License Compounds for Potential Treatment of Obesity, Diabetes and Related Disorders
HSMN NewsFeed,
14 Jun 2006:
Biopharmaceuticals, Licensing
[Pfizer, Bayer Pharmaceuticals, DGAT-1 inhibitor, Diabetes, Obesity]
|
Nexavar Receives Fast Track Designation from the FDA for Metastatic Liver Cancer
HSMN NewsFeed,
13 Jun 2006:
Biopharmaceuticals, Oncology, FDA
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Onyx Names Laura A. Brege Executive Vice President and Chief Business Officer
HSMN NewsFeed,
12 Jun 2006:
Biopharmaceuticals, Personnel
[Onyx Pharmaceuticals]
|
Ciphergen Biosystems, Inc. Establishes Scientific Advisory Board of Distinguished Scientists
HSMN NewsFeed,
12 Jun 2006:
Diagnostics, Personnel
[Ciphergen Biosystems]
|
Updated Overall Survival Analysis Presented on Nexavar Phase III Trial
HSMN NewsFeed,
5 Jun 2006:
Biopharmaceuticals, Oncology
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Serum HER-2/neu Change Predicts Clinical Outcome to Trastuzumab-Based Therapy
HSMN NewsFeed,
3 Jun 2006:
Oncology, Diagnostics
[Bayer HealthCare, HER-2/neu Test, trastuzumab]
|
ZIOPHARM Appoints Brian Schwartz, M.D. as Chief Medical Officer
HSMN NewsFeed,
1 Jun 2006:
Biopharmaceuticals, Personnel
[ZIOPHARM Oncology]
|
New Stroke Guidelines Underscore Importance of Aspirin for Women
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Neurology
[Bayer HealthCare, aspirin, stroke]
|
MorphoSys and Schering-Plough Sign R&D Agreement
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals
[MorphoSys , Schering-Plough, Combinatorial Antibody Library, HuCAL]
|
Seattle Genetics Names Pamela Trail, Ph.D., as Chief Scientific Officer
HSMN NewsFeed,
16 May 2006:
Biopharmaceuticals, Personnel
[Seattle Genetics]
|
Aerovance Secures $60 Million in Financing
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals, Venture Capital
[Aerovance, Aerovant]
|
Enrollment Completed in Phase III Studies of Nexavar for Patients With Metastatic Melanoma and Liver Cancer
HSMN NewsFeed,
3 May 2006:
Biopharmaceuticals, Oncology
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
Nexavar(R) Receives Positive Opinion from European Committee for Medicinal Products for Human Use
HSMN NewsFeed,
28 Apr 2006:
Biopharmaceuticals, Oncology, Regulatory
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib, kidney cancer]
|
FDA Grants Orphan Drug Designation to Nexavar for the Treatment of Hepatocellular Carcinoma
HSMN NewsFeed,
26 Apr 2006:
Biopharmaceuticals, Oncology, FDA
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib]
|
ZymoGenetics Names Michael Dwyer Senior Vice President of Marketing and Sales
HSMN NewsFeed,
25 Apr 2006:
Biopharmaceuticals, Personnel
[ZymoGenetics, rhThrombin]
|
Executive Board and Supervisory Board Recommend Acceptance of Bayer Offer for Takeover of Schering AG
HSMN NewsFeed,
18 Apr 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Schering AG, Bayer AG]
|
European Commission Grants Orphan Medicinal Product Designation to Nexavar for the Treatment of Hepatocellular Carcinoma
HSMN NewsFeed,
18 Apr 2006:
Biopharmaceuticals, Oncology, Regulatory
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, liver cancer]
|
Xavier Frapaise, M.D., to Join Ocera Therapeutics, Inc., as Chief Medical Officer
HSMN NewsFeed,
17 Apr 2006:
Biopharmaceuticals, Personnel
[Ocera Therapeutics]
|
AVELOX(R) Monotherapy as Effective as High-Dose Levofloxacin and Ceftriaxone Combination Therapy in Treating Patients With Severe Community-Acquired Pneumonia
HSMN NewsFeed,
7 Apr 2006:
Biopharmaceuticals
[Schering-Plough, AVELOX, moxifloxacin, MOTIV study]
|
CuraGen Appoints Dr. Frank M. Armstrong as Chief Executive Officer
HSMN NewsFeed,
30 Mar 2006:
Biopharmaceuticals, Personnel
[CuraGen]
|
Nexavar Approved in Switzerland for the Treatment of Patients with Advanced Kidney Cancer
HSMN NewsFeed,
30 Mar 2006:
Biopharmaceuticals, Oncology, Regulatory
[Bayer Pharmaceuticals, Onyx Pharmaceuticals, Nexavar, sorafenib, kidney cancer]
|
Schering AG Supports Bayer Offer
HSMN NewsFeed,
24 Mar 2006:
Biopharmaceuticals, Mergers & Acquisitions
[Schering, Bayer AG]
|
Nuvelo Appoints Shelly D. Guyer Vice President, Business Development and Investor Relations
HSMN NewsFeed,
23 Mar 2006:
Biopharmaceuticals, Personnel
[Nuvelo]
|
Study Shows LEVITRA(R) Treats Erectile Dysfunction Effectively in Men Taking Medications to Lower High Blood Pressure
HSMN NewsFeed,
22 Mar 2006:
Biopharmaceuticals
[Schering-Plough, GlaxoSmithKline, LEVITRA, vardenafil]
|
African American Heart Failure Trial Shows Women and Men Both Benefit from BiDil(R)
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Cardiology
[NitroMed, A-HeFT, BiDil]
|
Researchers Identify Gene Variations That May Determine Which Heart Failure Patients Are Likely to Benefit from Treatment With BiDil(R)
HSMN NewsFeed,
13 Mar 2006:
Biopharmaceuticals, Cardiology
[NitroMed, BiDil, A-HeFT, GRAHF study]
|
Aspirin Unsurpassed in Prevention of Heart Attack and Stroke in Wide Range of Patients
HSMN NewsFeed,
12 Mar 2006:
Biopharmaceuticals, Cardiology
[Bayer HealthCare, CHARISMA, antiplatelet therapy]
|
Alcon and Allergan Reach Agreement on Brimonidine 0.15% Patent Litigation
HSMN NewsFeed,
9 Mar 2006:
Biopharmaceuticals, Ophthalmology, Litigation, Licensing
[Alcon, Allergan, brimonidine]
|
Signet Laboratories Announces License Agreement with Bayer Diagnostics for Urinary Trypsin Inhibitor Immunoassays to Further Research Inflammatory Disease
HSMN NewsFeed,
1 Mar 2006:
Diagnostics, Licensing
[Signet Laboratories, Bayer , Urinary Trypsin Inhibitor]
|
Nuvelo and Bayer HealthCare Begin SONOMA-3, Second Phase 3 Trial of Alfimeprase in Patients With Central Venous Catheter Occlusion
HSMN NewsFeed,
27 Feb 2006:
Biopharmaceuticals
[Nuvelo, Bayer HealthCare, alfimeprase, central venous catheter occlusion]
|
Third Wave, Chiron, Bayer Dismiss HCV Patent Suit
HSMN NewsFeed,
23 Feb 2006:
Diagnostics, Litigation
[Third Wave Technologies, Chiron, Bayer HealthCare, hepatitis C]
|
Bayer and Onyx Initiate Phase III Non-Small Cell Lung Cancer Trial Studying Nexavar (sorafenib) Tablets in Combination With Two Chemotherapeutic Agents
HSMN NewsFeed,
16 Feb 2006:
Biopharmaceuticals, Oncology
[Bayer HealthCare, Onyx Pharmaceuticals, Nexavar, sorafenib, NSCLC]
|
Aerovance Appoints William J. Newell as President
HSMN NewsFeed,
8 Feb 2006:
Biopharmaceuticals, Personnel
[Aerovance]
|
CuraGen and TopoTarget Initiate Phase II Clinical Trial of PXD101 for T-Cell Lymphoma
HSMN NewsFeed,
1 Feb 2006:
Biopharmaceuticals, Oncology
[CuraGen, TopoTarget, PXD101, non-Hodgkin's lymphomas]
|
Bayer Diagnostics Announces First Fully-Automated High Sensitivity and High Precision Troponin Assays
HSMN NewsFeed,
31 Jan 2006:
Diagnostics, Cardiology, FDA
[Bayer HealthCare, TnI-Ultra, Troponin assays]
|
Abbott Laboratories Grants Bayer Diagnostics Rights to New Cancer and Transplantation Drug Tests
HSMN NewsFeed,
30 Jan 2006:
Diagnostics, Licensing
[Bayer HealthCare, Abbott, PSA, tacrolimus]
|
Peter Zundorf to Head up Schering's Oncology Business Area
HSMN NewsFeed,
26 Jan 2006:
Biopharmaceuticals, Personnel
[Schering AG]
|
BioAlliance Pharma Appoints Former GlaxoSmithKline Executive as Vice President of Sales & Marketing
HSMN NewsFeed,
24 Jan 2006:
Biopharmaceuticals, Personnel
[BioAlliance Pharma, Florence Dupre]
|
Nuvelo Receives FDA Fast Track Status for Alfimeprase
HSMN NewsFeed,
23 Jan 2006:
Biopharmaceuticals, FDA
[Nuvelo, alfimeprase, fast track designation, peripheral arterial occlusion]
|
Bayer HealthCare Introduces Kogenate(R) FS with BIO-SET(R) in the United States
HSMN NewsFeed,
19 Jan 2006:
Biopharmaceuticals
[Bayer HealthCare, Kogenate, BIO-SET]
|
XOMA Announces Senior Management Appointments
HSMN NewsFeed,
12 Jan 2006:
Biopharmaceuticals, Personnel
[XOMA]
|
Meghan Fitzgerald Joins Vion's Senior Management Team
HSMN NewsFeed,
10 Jan 2006:
Biopharmaceuticals, Personnel
[Vion Pharmaceuticals]
|
Sapphire Therapeutics, Inc. Builds Drug Development Team Through New Hires and Promotion
HSMN NewsFeed,
6 Jan 2006:
Biopharmaceuticals, Personnel
[Sapphire Therapeutics]
|
Nuvelo and Bayer HealthCare Enter Comprehensive Collaboration Agreement to Maximize Global Development and Commercialization of Alfimeprase
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals
[Nuvelo, Bayer HealthCare, alfimeprase, thrombolytic]
|
Metabasis Therapeutics, Inc. Announces Three Senior Management Additions to Development Team
HSMN NewsFeed,
5 Jan 2006:
Biopharmaceuticals, Personnel
[Metabasis Therapeutics]
|
ImClone Systems Names Cheryl Anderson Vice President, Regulatory Affairs
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, Personnel
[ImClone Systems]
|
|
|
 |
Additional items found:
The Network Archive contains
374 additional items
matching: Bayer
<< Members - click the icon at left to display. |
|
| |
|
|
|
|
Public
Feeds 
Full text >>